Literature DB >> 31927268

Oral treatment with Lactobacillus reuteri attenuates depressive-like behaviors and serotonin metabolism alterations induced by chronic social defeat stress.

Ruining Xie1, Pei Jiang2, Li Lin1, Jian Jiang1, Bin Yu3, Jingjing Rao4, Hui Liu1, Wei Wei1, Yi Qiao5.   

Abstract

BACKGROUND: Alterations in bidirectional gut-brain interactions are believed to be involved in the pathogenesis of neuropsychiatric diseases. Considering the putative connections among gut microbiota, neural function, and behavior, this study investigated the potential of microbe-induced gut-to-brain signaling to modulate the impact of stress on depressive-like behaviors and serotonin metabolism.
METHODS: Depression-susceptible mice induced by chronic social defeat stress received oral treatment of either Lactobacillus reuteri 3 (L. reuteri 3) or vehicle for 28 days, and alterations in behavior and serotonin metabolism were assessed. 16S rRNA sequencing and gas chromatograph were employed to analyze the gut microbiota community and short-chain fatty acids (SCFAs).
RESULTS: Treatment with L. reuteri 3 ameliorated depressive-like behaviors, suppressed the increase in the relative abundances of Clostridiales and Adlercreutzia, improved the decrease in abundances of Lactobacillus, Allobaculum, and Sutterella induced by stress, and significantly increased the proportion of Bifidobacterium. L. reuteri 3 reduced the acetate and total SCFAs levels in the depression group. Blood and colon 5-HT were decreased in depressive-like mice but were significantly ameliorated after L. reuteri 3 treatment. Moreover, L. reuteri 3 administration increased the expression of enzymes involved in serotonin biosynthesis but suppressed that of the enzymes involved in tryptophan metabolism along the kynurenine pathway in colon and prefrontal cortex.
CONCLUSIONS: Despite the complexity of the gut microbiota, exposure to a single microbial strain L. reuteri 3 can protect against depressive-like behaviors induced by chronic social defeat stress. The anti-depressive effects of L. reuteri 3 were associated with improved gut microbiota and serotonin metabolism.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depressive-like behaviors; Lactobacillus reuteri; Microbiota; Serotonin; Short-chain fatty acids; Stress

Mesh:

Substances:

Year:  2019        PMID: 31927268     DOI: 10.1016/j.jpsychires.2019.12.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  17 in total

1.  Sex-dependent changes in the microbiota profile, serum metabolism, and hormone levels of growing pigs after dietary supplementation with Lactobacillus.

Authors:  Dongyan Zhang; Hui Liu; Sixin Wang; Wei Zhang; Shuaiqin Wang; Yamin Wang; Haifeng Ji
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-18       Impact factor: 4.813

2.  Antidepressant Shugan Jieyu Capsule Alters Gut Microbiota and Intestinal Microbiome Function in Rats With Chronic Unpredictable Mild Stress -Induced Depression.

Authors:  Jingxuan Tan; Xixuan Li; Ying Zhu; Mitchell A Sullivan; Bin Deng; Xuejia Zhai; Yongning Lu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice.

Authors:  Jiayin Liu; Chuanqi Liu; Zhanyuan Gao; Lianyu Zhou; Junwei Gao; Yi Luo; Tianyao Liu; Xiaotang Fan
Journal:  Front Cell Infect Microbiol       Date:  2022-06-22       Impact factor: 6.073

Review 4.  Next-Generation Probiotics and Their Metabolites in COVID-19.

Authors:  Thomas Gautier; Sandrine David-Le Gall; Alaa Sweidan; Zohreh Tamanai-Shacoori; Anne Jolivet-Gougeon; Olivier Loréal; Latifa Bousarghin
Journal:  Microorganisms       Date:  2021-04-27

Review 5.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

6.  Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.

Authors:  Johanna Seifert; Hannah B Maier; Fabienne Führmann; Stefan Bleich; Susanne Stübner; Marcel Sieberer; Xueqiong Bernegger; Waldemar Greil; Cornelius Schüle; Sermin Toto; Renate Grohmann; Matthias A Reinhard
Journal:  J Neural Transm (Vienna)       Date:  2022-05-07       Impact factor: 3.850

Review 7.  Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy.

Authors:  Yilun Liu; Zhongmin Li; Yuanyu Wu; Xiabin Jing; Lin Li; Xuedong Fang
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

8.  A specific association between laxative misuse and suicidal behaviours in patients with anorexia nervosa and bulimia nervosa.

Authors:  Aiste Lengvenyte; Robertas Strumila; Laurent Maimoun; Maude Seneque; Emilie Olié; Patrick Lefebvre; Eric Renard; Philippe Courtet; Sebastien Guillaume
Journal:  Eat Weight Disord       Date:  2021-04-01       Impact factor: 4.652

9.  The Impact of Nutrition and Intestinal Microbiome on Elderly Depression-A Systematic Review.

Authors:  Blanka Klimova; Michal Novotny; Martin Valis
Journal:  Nutrients       Date:  2020-03-07       Impact factor: 5.717

10.  Indoxyl sulfate caused behavioral abnormality and neurodegeneration in mice with unilateral nephrectomy.

Authors:  Chiao-Yin Sun; Jian-Ri Li; Ya-Yu Wang; Shih-Yi Lin; Yen-Chuan Ou; Cheng-Jui Lin; Jiaan-Der Wang; Su-Lan Liao; Chun-Jung Chen
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.